International Conference on Antiviral Strategies, Vaccines and Immunology
ICAVSI
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track focuses on the latest developments in antiviral therapies and strategies aimed at combating viral infections. Researchers are invited to present innovative approaches and novel compounds that demonstrate efficacy against a range of viruses.
SDG 3
SDG 4
This session will explore cutting-edge technologies and methodologies in vaccine design and production. Topics may include mRNA vaccines, vector-based vaccines, and novel adjuvants that enhance immune responses.
SDG 3
SDG 9
This track examines the immune mechanisms activated during viral infections and their implications for disease progression. Presentations will cover cellular and humoral responses, as well as the role of immune evasion by viruses.
SDG 3
SDG 4
This session focuses on the molecular and cellular mechanisms underlying viral pathogenesis. Researchers are encouraged to discuss the interplay between viral factors and host responses that contribute to disease severity.
SDG 3
SDG 9
This track addresses the epidemiological trends and patterns of infectious diseases globally. Presentations will highlight surveillance data, outbreak investigations, and the impact of social determinants on disease spread.
SDG 3
SDG 10
This session invites discussions on clinical trials and studies evaluating the safety and efficacy of antiviral treatments. Researchers will share insights on patient outcomes and challenges faced in clinical settings.
SDG 3
SDG 9
This track focuses on public health interventions and strategies aimed at controlling viral outbreaks. Topics may include vaccination campaigns, contact tracing, and community engagement in outbreak response.
SDG 3
SDG 11
This session explores the application of immunotherapy in treating viral infections and enhancing host immunity. Presentations will cover monoclonal antibodies, immune checkpoint inhibitors, and therapeutic vaccines.
SDG 3
SDG 9
This track will delve into the assessment of vaccine safety profiles and their effectiveness in diverse populations. Researchers are encouraged to present findings from post-marketing surveillance and real-world studies.
SDG 3
SDG 9
This session addresses the challenges posed by emerging and re-emerging viral pathogens. Discussions will focus on preparedness strategies, rapid response frameworks, and lessons learned from recent outbreaks.
SDG 3
SDG 10
This track emphasizes the importance of international collaboration in addressing infectious diseases. Presentations will highlight successful partnerships, data sharing initiatives, and the role of global health organizations.
SDG 3
SDG 11